|
|
Other links at Articles > Allergy and Clinical Immunology |
| 1. |
Three-Dose IM Anthrax Vaccination Provides Effective Immune Priming
|
|
|
Anthrax vaccine administered in three doses by intramuscular (IM) injection provides noninferior immunological priming and reduces injection site reactions when compared with the licensed schedule of four doses administered subcutaneously (SC), an interim analysis of a phase IV clinical trial indicates. Reuters Health Information
|
| 2. |
Rituximab Reduces Brain Lesions, Clinical Relapses in RRMS
|
|
|
Results of a phase 2 trial show a single course of rituximab reduced both lesions on MRI and clinical relapses in relapsing-remitting multiple sclerosis. The results support the concept of B-cell involvement in the pathophysiology of the disease, researchers say. Medscape Medical News
|
|
|